BLTE
BELITE BIO, INC
NASDAQ · Healthcare · Biotechnology · US
$152.11
−0.04%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 79.99x
- P/E 2028E
- 24.61x
- P/S forward
- 27.58x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.89x
- Price / sales
- —
- Price / cash flow
- —
Enterprise value
- Enterprise value
- $6.1B
- EV / sales
- —
- EV / EBITDA
- -53.63x
- EV / EBIT
- -51.61x
- Market cap
- $6.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026